BridgeMD
Compares treatment options for Respiratory Tract Infections
Official title Intravenous Versus Oral Treatment of the Main Acute Infections
ClinicalTrials.gov ID: NCT06715306
What this study is testing
- What it's testing
- Patients admitted to the hospital with acute infections are often treated with intravenous (IV) antibiotics. Around 70% of these infections fall into three categories: respiratory tract infections, urinary tract infections, and cellulitis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Suspected respiratory tract infection, urinary tract infection, or cellulitis by the attending physician
- Planned or initiated intravenous antibiotic treatment
You likely can't join if
- if received more than two doses of intravenous antibiotics;
- systolic blood pressure \<90 mmHg;
- nausea and/or vomiting in more than one short-term instance during the last 2 days;
- suspected significantly reduced gastrointestinal absorption;
- confirmed plasma-lactate \> 2;
- pregnant or nursing;
See the full eligibility criteria
- Suspected respiratory tract infection, urinary tract infection, or cellulitis by the attending physician
- Planned or initiated intravenous antibiotic treatment
- if received more than two doses of intravenous antibiotics;
- systolic blood pressure \<90 mmHg;
- nausea and/or vomiting in more than one short-term instance during the last 2 days;
- suspected significantly reduced gastrointestinal absorption;
- confirmed plasma-lactate \> 2;
- pregnant or nursing;
- unable to give informed consent;
- severe immunodeficiency;
- urgent vital treatment needed.
The study team makes the final eligibility decision.
Where it's taking place
- Aabenraa, Southern Denmark, Denmark
- Copenhagen, Denmark
- Esbjerg, Denmark
- Herlev, Denmark
- Hvidovre, Denmark
- Kolding, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aabenraa, Southern Denmark, Denmark; Copenhagen, Denmark; Esbjerg, Denmark; Herlev, Denmark; Hvidovre, Denmark; Kolding, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.